TerrAscend Performance degli utili passati
Criteri Il passato verificati 0/6
TerrAscend ha registrato una crescita degli utili a un tasso medio annuo di 16.9%, mentre il settore Pharmaceuticals ha registrato utili in crescita a un tasso medio annuo di 23.4%. I ricavi sono stati in crescita a un tasso medio annuo di 8.7%.
Informazioni chiave
16.88%
Tasso di crescita degli utili
26.18%
Tasso di crescita dell'EPS
| Pharmaceuticals Crescita del settore | 23.06% |
| Tasso di crescita dei ricavi | 8.73% |
| Rendimento del capitale proprio | -26.01% |
| Margine netto | -10.81% |
| Ultimo aggiornamento sugli utili | 31 Mar 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Aggiornamento della narrazione • Jun 03
TSND: Active M&A Agenda And Margin Improvements Will Support Future Profitability
Analysts have adjusted their TerrAscend price target to CA$2.01 from CA$2.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend reiterated an active M&A agenda, with executives highlighting ongoing discussions for accretive acquisitions and interest in distressed assets in core markets, sourced from the first quarter 2026 results call.Aggiornamento della narrazione • May 07
TSND: Expanded Retail Footprint And Margin Gains Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from CA$2.00, citing updated assumptions around revenue growth, profit margins and a lower future P/E multiple that together support a modestly improved valuation outlook. What's in the News TerrAscend issued earnings guidance for the first quarter of 2026, anticipating net revenue of $65.5 million, compared with $66.1 million in the fourth quarter of 2025 and $64.3 million in the first quarter of 2025 (Key Developments).
Aggiornamento della narrazione • Apr 18
TSND: New CFO Hire And Share Buyback Will Support Future Upside
Analysts have modestly adjusted their price target on TerrAscend, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. Together, these factors refine their view of what the shares could be worth in CA$ terms.Aggiornamento della narrazione • Apr 04
TSND: New Brand Partnership And Share Buyback Will Support Future Upside
Analysts have nudged their TerrAscend price target modestly higher to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News TerrAscend announced the official launch of TYSON 2.0 products in Pennsylvania and Maryland, covering premium flower and high potency vape products under its exclusive partnership with the brand (Key Developments).Aggiornamento della narrazione • Mar 20
TSND: Expanded New Jersey Retail Footprint Will Support Future Profitability
Analysts have slightly adjusted their CA$ price target on TerrAscend, citing updated assumptions for revenue growth, profit margins, and a modest change in the expected future P/E multiple. What's in the News TerrAscend completed a share buyback tranche between October 1, 2025 and December 31, 2025, repurchasing 75,000 shares for $0.03m, equal to 0.02% of shares under the program first announced on August 20, 2025 (Key Developments).Aggiornamento della narrazione • Mar 04
TSND: Expanded New Jersey Footprint Will Support Future Profitability
Analysts have nudged their TerrAscend price target slightly higher to CA$2.00 from about CA$1.98, citing updated assumptions that include a modestly adjusted discount rate, changes to revenue growth and profit margin expectations, and a higher future P/E estimate. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey.Aggiornamento della narrazione • Feb 18
TSND: Union Chill Expansion Will Support Future Retail Scale And Margins
Analysts have trimmed their CA$ price target for TerrAscend, citing a slightly higher discount rate, a modestly reduced revenue outlook, and an improved profit margin profile that together reset expectations around the stock's future P/E level. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing Hunterdon County dispensary and bringing TerrAscend's New Jersey retail footprint to four locations (Key Developments).Articolo di analisi • Feb 12
More Unpleasant Surprises Could Be In Store For TerrAscend Corp.'s (TSE:TSND) Shares After Tumbling 27%
TerrAscend Corp. ( TSE:TSND ) shares have had a horrible month, losing 27% after a relatively good period beforehand...Aggiornamento della narrazione • Feb 04
TSND: Union Chill Deal Will Drive Future Retail And Margin Upside
Analysts have trimmed their price target on TerrAscend to about US$1.25 from roughly US$1.50, citing reduced revenue growth expectations and a lower future P/E multiple, partly offset by higher projected profit margins. What's in the News TerrAscend closed its previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County, New Jersey, and bringing its retail footprint in the state to four dispensaries (Key Developments).Aggiornamento della narrazione • Jan 21
TSND: Expanded Retail Footprint And Licensing Will Support Future Profitability
Analysts have modestly revised their price target on TerrAscend, citing slightly firmer profit margin expectations and a small adjustment to revenue trends and future P/E assumptions. Together, these factors support a refined fair value estimate without a material change in the overall valuation level.Aggiornamento della narrazione • Jan 06
TSND: Expanded Mid Atlantic Footprint And Licensing Will Support Higher Profitability
Analysts have nudged their price target on TerrAscend toward about $2.00, reflecting updated views that incorporate higher projected profit margins, a lower assumed future P/E multiple near 43, and adjusted revenue expectations. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing dispensary in Hunterdon County and bringing TerrAscend's New Jersey retail footprint to four dispensaries (Key Developments).Aggiornamento della narrazione • Dec 15
TSND: Licensing Expansion Into Mid Atlantic Markets Will Drive Stronger Profitability
Analysts have raised their price target on TerrAscend by approximately $2.25 to about $1.98 per share. They cited expectations for stronger profit margins and a more reasonable future earnings multiple, even as they moderate revenue growth assumptions and apply a slightly higher discount rate.Articolo di analisi • Dec 14
TerrAscend Corp.'s (TSE:TSND) Shares Climb 123% But Its Business Is Yet to Catch Up
TerrAscend Corp. ( TSE:TSND ) shares have had a really impressive month, gaining 123% after a shaky period beforehand...Articolo di analisi • Nov 09
Earnings Release: Here's Why Analysts Cut Their TerrAscend Corp. (TSE:TSND) Price Target To CA$1.75
TerrAscend Corp. ( TSE:TSND ) shareholders are probably feeling a little disappointed, since its shares fell 4.0% to...Articolo di analisi • Oct 30
TerrAscend Corp.'s (TSE:TSND) 27% Share Price Plunge Could Signal Some Risk
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 27% over the previous 30 days, handing back...Articolo di analisi • Jun 11
Some TerrAscend Corp. (TSE:TSND) Shareholders Look For Exit As Shares Take 34% Pounding
Unfortunately for some shareholders, the TerrAscend Corp. ( TSE:TSND ) share price has dived 34% in the last thirty...Articolo di analisi • Apr 27
TerrAscend Corp. (TSE:TSND) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely
The TerrAscend Corp. ( TSE:TSND ) share price has fared very poorly over the last month, falling by a substantial 30...
Nuova narrazione • Apr 02
ERP Implementation And Ohio Expansion Will Improve Operational Efficiency
Strategic expansions into new markets like Ohio and New Jersey are poised to enhance revenue and profitability through streamlined operations and vertical integration.Articolo di analisi • Mar 05
With A 29% Price Drop For TerrAscend Corp. (TSE:TSND) You'll Still Get What You Pay For
To the annoyance of some shareholders, TerrAscend Corp. ( TSE:TSND ) shares are down a considerable 29% in the last...Articolo di analisi • Jan 03
These 4 Measures Indicate That TerrAscend (TSE:TSND) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Sep 03
Is TerrAscend (TSE:TSND) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Apr 25
TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Articolo di analisi • Mar 10
What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
The TerrAscend Corp. ( TSE:TSND ) share price has softened a substantial 25% over the previous 30 days, handing back...Articolo di analisi • Jan 24
Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
TerrAscend Corp. ( TSE:TSND ) shareholders would be excited to see that the share price has had a great month, posting...Articolo di analisi • Dec 25
Is TerrAscend (TSE:TSND) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Aug 13
TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Jul 03
TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors
When close to half the companies in the Pharmaceuticals industry in Canada have price-to-sales ratios (or "P/S") below...Ripartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come TerrAscend guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Mar 26 | 262 | -28 | 87 | 0 |
| 31 Dec 25 | 261 | -29 | 86 | 0 |
| 30 Sep 25 | 299 | -71 | 107 | 0 |
| 30 Jun 25 | 300 | -77 | 110 | 0 |
| 31 Mar 25 | 263 | -26 | 91 | 0 |
| 31 Dec 24 | 268 | -28 | 91 | 0 |
| 30 Sep 24 | 288 | -81 | 96 | 0 |
| 30 Jun 24 | 312 | -74 | 101 | 0 |
| 31 Mar 24 | 317 | -81 | 109 | 0 |
| 31 Dec 23 | 251 | -36 | 84 | 0 |
| 30 Sep 23 | 300 | -50 | 121 | 0 |
| 30 Jun 23 | 277 | -342 | 119 | 0 |
| 31 Mar 23 | 269 | -311 | 122 | 0 |
| 31 Dec 22 | 248 | -304 | 116 | 0 |
| 30 Sep 22 | 212 | -298 | 94 | 0 |
| 30 Jun 22 | 195 | 59 | 88 | 0 |
| 31 Mar 22 | 189 | 13 | 76 | 0 |
| 31 Dec 21 | 194 | 13 | 75 | 0 |
| 30 Sep 21 | 211 | -96 | 88 | 0 |
| 30 Jun 21 | 200 | -165 | 80 | 0 |
| 31 Mar 21 | 175 | -144 | 73 | 0 |
| 31 Dec 20 | 132 | -125 | 61 | 0 |
| 30 Sep 20 | 118 | -159 | 54 | 1 |
| 30 Jun 20 | 99 | -156 | 55 | 1 |
| 31 Mar 20 | 75 | -155 | 49 | 1 |
| 31 Dec 19 | 64 | -161 | 46 | 1 |
| 30 Sep 19 | 48 | -44 | 41 | 0 |
| 30 Jun 19 | 30 | -33 | 32 | 0 |
| 31 Mar 19 | 16 | -23 | 25 | 0 |
| 31 Dec 18 | 5 | -16 | 17 | 0 |
| 30 Sep 18 | 1 | -9 | 12 | 0 |
| 30 Jun 18 | 0 | -8 | 7 | 0 |
| 31 Mar 18 | 0 | -7 | 6 | 0 |
| 31 Dec 17 | 0 | -5 | 5 | 0 |
| 30 Sep 17 | 0 | -5 | 4 | 0 |
| 30 Jun 17 | 0 | -4 | 3 | 0 |
| 31 Mar 17 | 0 | -1 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 1 | 0 |
Guadagni di qualità: TSND al momento non è redditizia.
Margine di profitto in crescita: TSND al momento non è redditizia.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: TSND non è redditizia, ma ha ridotto le perdite negli ultimi 5 anni a un tasso pari a 16.9% all'anno.
Accelerare la crescita: Impossibile confrontare la crescita degli utili di TSND nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia
Guadagni vs Settore: TSND non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Pharmaceuticals ( 64.6% ).
Rendimento del capitale proprio
ROE elevato: TSND ha un Return on Equity negativo ( -26.01% ), in quanto al momento non è redditizio.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/06/18 21:56 |
| Prezzo dell'azione a fine giornata | 2026/06/18 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
TerrAscend Corp. è coperta da 9 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Matt Bottomley | Canaccord Genuity |
| Shaan Mir | Canaccord Genuity |